Fusion Pharmaceuticals Inc. (FUSN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

270 LONGWOOD ROAD SOUTH HAMILTON, ONTARIO, CANADA L8P 0A6

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Fusion connects alpha particle emitting isotopes to targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion's lead program, FPI-1434, is currently in a Phase 1 clinical trial. The Company is advancing a pipeline of targeted radiopharmaceutical cancer therapies for a broad array of tumor types based upon its proprietary platform technology.

Data as of 2021-09-19 13:28:19 -0400
Market Cap386.316 Million Shares Outstanding43.02 Million Avg 30-day Volume57.865 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.36351 52-week High/Low13.89 / 6.61 Next Earnings Date2021-11-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from FUSN instead.

View recent insider trading info

Funds Holding FUSN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FUSN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

12 Thousand total shares from 4 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GANNON STEVEN

  • Director
12,000 2021-08-23 4

CAGNONI PABLO J

  • Director
17,000 2021-06-04 1

DUNCAN BARBARA GAYLE

  • Director
17,000 2021-06-04 1

PRESTON HEATHER

  • Director
17,000 2021-06-04 1

KHUONG CHAU QUANG

  • Director
17,000 2021-06-04 1

BERGSTROM DONALD A

  • Director
17,000 2021-06-04 3

LEE PHILINA

  • Director
17,000 2021-06-04 3

O'LEARY JAMES J CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-04 1

CROWLEY JOHN J CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-04 1

VALLIANT JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-02-04 1

BURAK ERIC CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-02-04 1

ADAMS STREET PARTNERS LLC

  • 10% Owner
No longer subject to file 2020-12-24 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GANNON STEVEN - Director

2021-08-23 18:28:03 -0400 2021-08-23 P 2,829 $7.99 a 12,000 direct 1.083 12.2744 13.2371 5 0.0 1

GANNON STEVEN - Director

2021-08-20 16:10:12 -0400 2021-08-19 P 3,000 $8.05 a 9,171 direct 1.9007 15.3893 15.3893 6 0.0 1

GANNON STEVEN - Director

2021-08-20 16:10:12 -0400 2021-08-18 P 171 $8.05 a 6,171 direct 1.9007 15.3893 15.3893 6 0.0 1

GANNON STEVEN - Director

2021-08-17 16:05:12 -0400 2021-08-16 P 6,000 $8.10 a 6,000 direct -3.3613 0.8403 0.8403 6 -3.3613 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 22:15:03 UTC -11.7835 11.8535 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 21:45:03 UTC -11.7835 11.8535 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 21:15:03 UTC -11.7835 11.8535 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 20:45:02 UTC -11.5668 11.6368 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 20:15:03 UTC -11.5668 11.6368 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 19:45:03 UTC -11.5668 11.6368 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 19:15:03 UTC -11.5668 11.6368 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 18:45:03 UTC -11.3833 11.4533 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 18:15:04 UTC -11.3833 11.4533 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 17:45:04 UTC -11.3833 11.4533 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 17:15:03 UTC -11.3833 11.4533 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 16:45:03 UTC -11.3833 11.4533 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 16:15:03 UTC -11.3833 11.4533 1200000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 15:45:03 UTC -11.3833 11.4533 950000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 15:15:03 UTC -11.3833 11.4533 950000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 14:45:03 UTC -11.0634 11.1334 950000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 14:15:03 UTC -11.0634 11.1334 950000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 13:45:04 UTC -11.0634 11.1334 950000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 13:15:03 UTC -11.0634 11.1334 950000
FUSION PHARMACEUTICALS INC FUSN 2021-09-22 12:45:03 UTC -11.0634 11.1334 950000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments